Total Funding
7
18
Total FundingSeries C raised
Growth Score
-9 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
617577
Spinal Restoration develops early-intervention, minimally invasive therapies for chronic low back, disk, and discogenic pain.
Jeff Frizell: Chief Financial OfficerPast Role: Sulzer Orthopedics, Global Vice President of Finance
Steven Whitlock: Founder
About the Company
Spinal Restoration was formed to identify and develop new, early intervention, minimally invasive therapies for the treatment of chronic low back pain. The company’s first endeavor is the Biostat® System, a proprietary resorbable biologic compound and delivery system for the treatment of chronic disc pain. The new treatment specifically targets
discogenic pain, which represents the single largest population of patients—an estimated four million adults—who suffer from chronic low back pain annually.
